These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 26370671

  • 1. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
    Batista FA, Ward LS, Marcello MA, Martins MB, Peres KC, Torricelli C, Bufalo NE, Soares FA, da Silva MJ, Assumpção LV.
    J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A.
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [Abstract] [Full Text] [Related]

  • 3. PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.
    Lacroix L, Mian C, Barrier T, Talbot M, Caillou B, Schlumberger M, Bidart JM.
    Eur J Endocrinol; 2004 Sep; 151(3):367-74. PubMed ID: 15362967
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
    Finley DJ, Arora N, Zhu B, Gallagher L, Fahey TJ.
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
    [Abstract] [Full Text] [Related]

  • 11. Methylation markers differentiate thyroid cancer from benign nodules.
    Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ.
    J Endocrinol Invest; 2018 Feb; 41(2):163-170. PubMed ID: 28612287
    [Abstract] [Full Text] [Related]

  • 12. PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY.
    Halászlaki C, Tóbiás B, Balla B, Kósa JP, Horányi J, Bölöny E, Nagy Z, Speer G, Járay B, Székely E, Istók R, Székely T, Putz Z, Dank M, Lakatos P, Takács I.
    Endocr Pract; 2016 Sep; 22(9):1081-7. PubMed ID: 27214302
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM, Ibrahim TR.
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [Abstract] [Full Text] [Related]

  • 14. Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.
    Borrelli N, Ugolini C, Giannini R, Antonelli A, Giordano M, Sensi E, Torregrossa L, Fallahi P, Miccoli P, Basolo F.
    Cancer Cytopathol; 2016 May; 124(5):340-9. PubMed ID: 26749005
    [Abstract] [Full Text] [Related]

  • 15. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.
    Jug RC, Datto MB, Jiang XS.
    Cancer Cytopathol; 2018 Jul; 126(7):471-480. PubMed ID: 29637728
    [Abstract] [Full Text] [Related]

  • 18. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z, Hardin H, Montemayor-Garcia C, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV.
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [Abstract] [Full Text] [Related]

  • 19. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL.
    Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
    [Abstract] [Full Text] [Related]

  • 20. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
    Simms A, Jacob RP, Cohen C, Siddiqui MT.
    Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.